Active ingredients: denosumab
What it is used for
Prevention of skeletal related events in patients with multiple myeloma and in patients with bone metastases from solid tumours. Treatment of giant cell tumour of bone in adults or skeletally mature adolescents that is recurrent, or unresectable, or resectable but associated with severe morbidity. Treatment of hypercalcaemia of malignancy that is refractory to intravenous bisphosphonate.
How to take it
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
- The way to take this medicine: Subcutaneous
- Store at 2 to 8 degrees Celsius
- Do not Shake
- Protect from direct sunlight
- Lifetime is 3 Years.
Always read the label. If symptoms persist see your healthcare professional.
Clear, colourless to slightly yellow solution
Do I need a prescription?
This medicine is available from a pharmacist and requires a prescription. It is
Pregnant or planning a pregnancy?
For the active ingredient denosumab
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
For side effects, taking other medicines and more
Download consumer medicine information leaflet (pdf)